Zelira Therapeutics Ltd. has released a press release.
Long Term Suspended Entities
Earlier from Zelira Therapeutics
- Suspension from Quotation
- Quarterly Activities/Appendix 4C Cash Flow Report
- Transformative US$33M Fundraising into Zeliras HOPE 1 SPV
- Zelira receives $1,070,000 R&D Tax Incentive Scheme Refund